Margaret M Esiri Selected Research

Margaret M Esiri Research Topics

Disease

16	Alzheimer Disease (Alzheimer's Disease) 02/2016 - 03/2002
11	Dementia (Dementias) 02/2016 - 03/2002
10	Multiple Sclerosis 01/2022 - 04/2006
6	Inflammation (Inflammations) 02/2022 - 04/2013
5	Demyelinating Diseases (Demyelinating Disease) 08/2017 - 07/2006
5	Cognitive Dysfunction 06/2011 - 03/2002
4	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2014 - 10/2007
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2014 - 07/2013
2	Amyloid Plaque 01/2012 - 06/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2010 - 12/2006
1	Arteriolosclerosis 10/2020
1	Cerebral Small Vessel Diseases 10/2020
1	Nervous System Diseases (Neurological Disorders) 10/2019
1	Hematoma 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2018
1	Neuroinflammatory Diseases 10/2018
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Leukoaraiosis 11/2014
1	Hypertension (High Blood Pressure) 11/2014
1	Pathologic Processes 05/2014
1	Ischemia 07/2013
1	Amyloid angiopathy 01/2012
1	Hippocampal Sclerosis 12/2011
1	Down Syndrome (Down's Syndrome) 12/2011
1	Mental Disorders (Mental Disorder) 02/2011
1	Ischemic Stroke 05/2010
1	Stroke (Strokes) 05/2010
1	Autoimmune Diseases (Autoimmune Disease) 03/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2008
1	Corticobasal Degeneration 12/2006
1	Tauopathies 12/2006
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2006
1	Hyperplasia 03/2004
1	Adenoma (Adenomas) 03/2004
1	Giant Cell Arteritis (Horton Disease) 11/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 05/2014 - 03/2004
3	ParaffinIBA 02/2022 - 07/2013
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 04/2013
3	Myelin ProteinsIBA 05/2014 - 07/2006
2	Formaldehyde (Formol)FDA Link 02/2022 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 05/2013
2	Fibrinogen (Factor I)FDA Link 10/2018 - 11/2014
2	Amyloid (Amyloid Fibrils)IBA 02/2016 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2003
2	Myelin-Associated GlycoproteinIBA 05/2014 - 07/2013
2	Apolipoproteins E (ApoE)IBA 05/2013 - 06/2006
2	Peptides (Polypeptides)IBA 06/2011 - 03/2009
2	Cholinergic Agents (Cholinergics)IBA 09/2006 - 06/2006
2	Serotonin (5 Hydroxytryptamine)IBA 07/2003 - 07/2002
1	Complement System Proteins (Complement)IBA 02/2022
1	estropipate (Ogen)FDA LinkGeneric 08/2017
1	FibrinIBA 08/2017
1	Immunoglobulin A (IgA)IBA 05/2016
1	RelaxinIBA 02/2016
1	Apolipoprotein E4IBA 01/2015
1	Immunoglobulin G (IgG)IBA 11/2014
1	Blood Proteins (Serum Proteins)IBA 11/2014
1	Endothelin-1 (Endothelin 1)IBA 05/2014
1	ImmunosorbentsIBA 12/2012
1	EnzymesIBA 12/2012
1	AntibodiesIBA 06/2012
1	CopperIBA 01/2012
1	AluminumIBA 01/2012
1	IronIBA 01/2012
1	Flavin-Adenine Dinucleotide (FAD)IBA 12/2011
1	AMPA Receptors (AMPA Receptor)IBA 06/2011
1	AMPA 2 glutamate receptor ionotropicIBA 06/2011
1	interleukin-21 (interleukin 21)IBA 02/2011
1	Interleukin-21 ReceptorsIBA 02/2011
1	Serotonin AgentsIBA 02/2011
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2010
1	HemosiderinIBA 12/2010
1	CannabinoidsIBA 12/2010
1	Neuroprotective AgentsIBA 05/2010
1	A-factor (Streptomyces)IBA 05/2010
1	purinoceptor P2Y6IBA 08/2008
1	UridineIBA 08/2008
1	NucleotidesIBA 08/2008
1	Interleukin-17 (Interleukin 17)IBA 01/2008
1	Advanced Glycation End ProductsIBA 10/2007
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 10/2007
1	Messenger RNA (mRNA)IBA 12/2006
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2006
1	GTP-Binding Proteins (G-Protein)IBA 09/2006
1	Muscarinic M1 ReceptorIBA 09/2006
1	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2006
1	Amyloid beta-PeptidesIBA 06/2006
1	Citalopram FDA LinkGeneric 07/2003
1	5-HT1A Serotonin ReceptorIBA 06/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2002
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2002

Therapy/Procedure

2	Therapeutics 05/2013 - 09/2006
1	Drug Therapy (Chemotherapy) 01/2019